These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33638642)

  • 21. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.
    Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
    Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
    Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity Relationship of Indomethacin Derivatives as IDO1 Inhibitors.
    Obata T; Shiratani S; Nada T; Kasaya Y; Arisawa M; Shuto S; Tanaka M
    Anticancer Res; 2021 May; 41(5):2287-2296. PubMed ID: 33952454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Zheng Y; Stafford PM; Stover KR; Mohan DC; Gupta M; Keske EC; Schiavini P; Villar L; Wu F; Kreft A; Thomas K; Raaphorst E; Pasangulapati JP; Alla SR; Sharma S; Mittapalli RR; Sagamanova I; Johnson SL; Reed MA; Weaver DF
    ChemMedChem; 2021 Jul; 16(14):2195-2205. PubMed ID: 33759400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
    Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of indoleamine-2,3-dioxigenase 1 inhibitory activity of 4,6-disubstituted indazole derivatives and their heme binding affinity.
    Tsujino H; Uno T; Yamashita T; Katsuda M; Takada K; Saiki T; Maeda S; Takagi A; Masuda S; Kawano Y; Meguro K; Akai S
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126607. PubMed ID: 31431359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays.
    Ge H; Mao L; Zhao J; Wang Y; Shi D; Yang X; Wang X; Liu H; Yao X
    J Comput Aided Mol Des; 2021 May; 35(5):679-694. PubMed ID: 33905074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of immunosuppressive indoleamine 2,3-dioxygenase by targeting the heme and apo-form.
    Pradhan N; Akhtar N; Nath B; Peña-García J; Gupta A; Pérez-Sánchez H; Kumar S; Manna D
    Chem Commun (Camb); 2021 Jan; 57(3):395-398. PubMed ID: 33326535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1.
    Peng YH; Ueng SH; Tseng CT; Hung MS; Song JS; Wu JS; Liao FY; Fan YS; Wu MH; Hsiao WC; Hsueh CC; Lin SY; Cheng CY; Tu CH; Lee LC; Cheng MF; Shia KS; Shih C; Wu SY
    J Med Chem; 2016 Jan; 59(1):282-93. PubMed ID: 26642377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective.
    Feng X; Liao D; Liu D; Ping A; Li Z; Bian J
    J Med Chem; 2020 Dec; 63(24):15115-15139. PubMed ID: 33215494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy.
    Liu C; Nan Y; Xia Z; Gu K; Chen C; Dong X; Ju D; Zhao W
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127038. PubMed ID: 32088128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation.
    Coluccia A; Passacantilli S; Famiglini V; Sabatino M; Patsilinakos A; Ragno R; Mazzoccoli C; Sisinni L; Okuno A; Takikawa O; Silvestri R; La Regina G
    J Med Chem; 2016 Nov; 59(21):9760-9773. PubMed ID: 27690429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design.
    Yeh TK; Song JS; Chang PW; Yu JC; Chang CH; Liao FY; Tien YW; Kuppusamy R; Li AS; Chen CH; Chen CW; Lin LM; Chang HH; Huang CH; Yao JY; Wu MH; Peng YH; Hsueh CC; Hsiao WC; Chen PH; Lin CY; Hsieh SH; Shih C; Hung MS; Wu SY; Kuo CC; Ueng SH
    Eur J Med Chem; 2022 Feb; 229():114043. PubMed ID: 34929581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and activity of novel indirubin derivatives.
    Sun B; Wang J; Liu L; Mao L; Peng L; Wang Y
    Chem Biol Drug Des; 2021 Mar; 97(3):565-571. PubMed ID: 32914538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of bicyclic carboxylic acid derivatives as IDO1 inhibitors.
    Cai S; Yang X; Chen P; Liu X; Zhou J; Zhang H
    Bioorg Chem; 2020 Jan; 94():103356. PubMed ID: 31785855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A theranostic probe of indoleamine 2,3-dioxygenase 1 (IDO1) for small molecule cancer immunotherapy.
    Wu Y; Zhang Y; Chen X; Hu Y; Dong G; Guo Y; Sheng C
    Eur J Med Chem; 2021 Mar; 213():113163. PubMed ID: 33482599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and antitumor study of a series of N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors.
    Chen S; Guo W; Liu X; Sun P; Wang Y; Ding C; Meng L; Zhang A
    Eur J Med Chem; 2019 Oct; 179():38-55. PubMed ID: 31233921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth.
    Panda S; Pradhan N; Chatterjee S; Morla S; Saha A; Roy A; Kumar S; Bhattacharyya A; Manna D
    Sci Rep; 2019 Dec; 9(1):18455. PubMed ID: 31804586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies.
    Griglio A; Torre E; Serafini M; Bianchi A; Schmid R; Coda Zabetta G; Massarotti A; Sorba G; Pirali T; Fallarini S
    Bioorg Med Chem Lett; 2018 Feb; 28(4):651-657. PubMed ID: 29398544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.